期刊文献+

反相高效液相色谱法测定尿中吡啶醚和脱氧吡啶醚 被引量:15

Analysis of the Pyridinoline and Deoxypyridinoline in Urine by Reversed Phase High Performance Liquid Chromatography (RP HPLC)
下载PDF
导出
摘要 尿中吡啶醚(pyridinoline,PYD)和脱氧吡啶醚(deoxypyridinoline,DPD)是骨代谢特异的生化指标。应用高效液相色谱法(HPLC)建立了尿中PYD和DPD的测定方法。尿液用6mol/LHCl水解后,以纤维素CF1小柱提取,然后用HPLC测定;色谱系统为SpherisorbC18反相色谱柱,流动相组成为15%甲醇添加0.1%七氟丁酸,流速为1.2mL/min。系统的检测限:PYD为10nmol/L,DPD为7nmol/L;回收率:PYD为91.5%,DPD为106.1%;日内变异系数:PYD为1.39%,DPD为0.16%;日间变异系数:PYD为3.71%,DPD为1.32%。结果表明,方法具有简单、准确和特异的优点。 A method for the simultaneous and rapid determination of pyridinoline and deoxypyridinoline in urine using RP HPLC has been established. After hydrolysis for 18 hours at 107℃ in 6mol/L HCl, the urine sample was prefractionated by partition chromatography using a column packed with cellulose CF1. The appropriate fractions were freeze dried. The samples were analyzed by HPLC with a 5μm Spherisorb C18 column, a mobile phase of MeOH/H2O containing 01% heptafluorobutyric acid at a rate of 12mL/min and fluorescence detector monitoring at λex 290nm and λem 400nm. The limit of a detection for PYD was 10nmol/L and DPD 7nmol/L. The recovery of PYD was 915% and that of DPD was 1061%. Within day CV for the two compounds were 139% and 016% respectively and day to day CV 371% and 132% respectively.
出处 《色谱》 CAS CSCD 北大核心 1997年第6期521-523,共3页 Chinese Journal of Chromatography
基金 1996年广东省科委基金 广东省卫生厅基金
关键词 吡啶醚 脱氧吡啶醚 人尿 骨代谢疾病 HPLC high performance liquid chromatography, pyridinoline, deoxypyridinoline, human urine, bone metabolic disease
  • 相关文献

同被引文献55

  • 1杜维霞,郭仕林,姬英.糖尿病Ⅱ型患者的骨矿含量分析[J].中国骨质疏松杂志,1998,4(4):43-45. 被引量:7
  • 2刘波,于世凤,庞淑珍.新伐他汀体外对破骨细胞性骨吸收及大鼠骨代谢的影响[J].中国骨质疏松杂志,2005,11(3):351-355. 被引量:13
  • 3李伟民,王伟.去势后骨质疏松大鼠与氨基胍的防治研究[J].陕西医学杂志,2006,35(3):302-304. 被引量:3
  • 4An Z,Chen J,Wang WZ,et al.Bone quantity peak and osteoporosis[J].The Journal of Morden Rehebilitation,2001,5(2):14
  • 5Caughan GW.Osteoporosis in chronic liver disease:pathogenesis,risk factor and management[J].Dignosis Disease,1994,12(4):23
  • 6Cortizo AM,Caporossi M,Lettieri G,et al.Vanadate induced nitric oxide production:role in osteoblast growth and differentiation[J].Eur J Pharmacal,2007,407(3):279-285.
  • 7Spencer CP,Codsland IF,Cooper AJ,et al.Effects of oral and transdermal 17β-estradial with oral norethindrome acetate on insulin sensitivity,seeretion,and elimination in postmenopausol women[J].Metabolism,2006,55 (6):742-747.
  • 8Gaspard UJ,Gottal JM.Postmenopausol changes of lipid and glucose metabolism:A review of their main aspect[J].Maturitas,2008,20(13):171-178.
  • 9Munch G,Thome J,Foley P,et al.Advanced glycation end products in ageing and Alzheimer's disease[J].Brain Res Rrain Res Rev,2003,29(2):134-143.
  • 10Yoon YM, Oh CD, Kim DY, et al. Epidermal growth factor negatively regulates chondrogenesis of mesonchymal cells by modulating the protein kinase C- alpha, Erk- 1 and p38 MAPK signaling pathways.J BiolChem, 2000, 275 (16): 12353

引证文献15

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部